Dextromethorphan Hbr And Guaifenesin
NDC Package 81033-213-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dextromethorphan Hbr And Guaifenesin is ▪ Temporarily relieves cough due to minor throat and bronchial irritations as my occur with a cold▪ Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-213 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
81033-213-50
Package Description
50 CUP, UNIT-DOSE in 1 CARTON / 5 mL in 1 CUP, UNIT-DOSE
Product Code
81033-213
11-Digit Billing Format
81033021350
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1020138 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution
  • RxCUI: 1020138 - dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution
  • RxCUI: 1020138 - dextromethorphan HBr 20 MG / guaifenesin 400 MG per 20 ML Oral Solution
  • RxCUI: 1020138 - dextromethorphan HBr 5 MG / guaifenesin 100 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Dextromethorphan Hbr And Guaifenesin
Dosage Form
-
Usage Information
▪ Temporarily relieves cough due to minor throat and bronchial irritations as my occur with a cold▪ Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

Regulatory & Marketing

Labeler Name
Kesin Pharma Corporation
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-15-2023
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (81033-213). Click a package code to view its specific billing and regulatory data.

81033-213-51
50 CUP, UNIT-DOSE in 1 CARTON / 10 mL in 1 CUP, UNIT-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81033-213-50 identifies a specific commercial package of 50 cup, unit-dose in 1 carton / 5 ml in 1 cup, unit-dose of Dextromethorphan Hbr And Guaifenesin, labeled by Kesin Pharma Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kesin Pharma Corporation on November 15, 2023. The current certification is valid through December 31, 2024.

How is this Kesin Pharma Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033021350. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81033-213-50
11-Digit CMS (5-4-2)
81033-0213-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.